Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

about

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Item

http://www.wikidata.org/entity/Q38891536

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characteristics and outcome of ...... h or without arsenic trioxide.

@en

type

Item

label

Characteristics and outcome of ...... h or without arsenic trioxide.

@en

prefLabel

Characteristics and outcome of ...... h or without arsenic trioxide.

@en

P1476

Characteristics and outcome of ...... h or without arsenic trioxide.

@en

P2093

A Benner

http://www.w3.org/2001/XMLSchema#string

A D Ho

http://www.w3.org/2001/XMLSchema#string

A K Burnett

http://www.w3.org/2001/XMLSchema#string

A Krämer

http://www.w3.org/2001/XMLSchema#string

B D Smith

http://www.w3.org/2001/XMLSchema#string

C Röllig

http://www.w3.org/2001/XMLSchema#string

C Thiede

http://www.w3.org/2001/XMLSchema#string

D Grimwade

http://www.w3.org/2001/XMLSchema#string

E H Estey

http://www.w3.org/2001/XMLSchema#string

G Ehninger

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Acute promyelocytic leukemia: where did we start, where are we now, and the future

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia

All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.

P2888

leu.2017.92

P304

2347-2354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2017.92

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084128359

http://www.w3.org/2001/XMLSchema#string

P698

28322237

http://www.w3.org/2001/XMLSchema#string

P932

6037311

http://www.w3.org/2001/XMLSchema#string